|
SYRS Syros Pharmaceuticals Inc 1556263 |
| Balance Sheet |
|
Current Assets
|
63,931,000 |
|
Assets
|
84,995,000 |
|
Current Liabilities
|
28,392,000 |
|
Liabilities
|
96,118,000 |
|
Equity
|
-11,123,000 |
|
Shares Out
|
26,728,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-81,454,000 |
|
Investing Cash Flow
|
427,000 |
| Market Analysis |
Market Cap
|
54,825,961 |
|
Price
|
0.12 |
|
BVPS
|
19.03 |
|
PB
|
0.01 |
|
EPS
|
-4.30 |
|
PS
|
0.15 |
|
FCF
|
-81,027,000 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/31 |
-0.16 |
11/12 |
|
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SYRS documents filed with the SEC.
SYRS Filings
Clear
